DPP Zyme III
Natural health product licensed in Canada
- Other names
- DPP Zyme, DPP Zyme 2.0, DPP Zyme II
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80047319
- Status
- Active licence
- Licence date
- 17 December 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Dioxyde de silicium, Cellulose microcristalline, Dextrine, Stéaryl fumarate de sodium, Hypromellose, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 1 day ; maximum: 3 days |
Uses authorised in Canada
Digestive aid. Digestive enzyme. Helps digest proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you have a gastrointestinal lesion/ulcer, are taking an anticoagulant/ blood thinner or an anti-inflammatory, or are having surgery, consult a health care practitioner prior to use. If you are pregnant or breastfeeding, consult a health care practitioner prior to use.
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80047319
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.